Vir Biotechnology Stock Market Value
VIR Stock | USD 10.27 0.04 0.39% |
Symbol | Vir |
Vir Biotechnology Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vir Biotechnology. If investors know Vir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vir Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.585 | Earnings Share (3.93) | Revenue Per Share | Quarterly Revenue Growth (0.1) | Return On Assets |
The market value of Vir Biotechnology is measured differently than its book value, which is the value of Vir that is recorded on the company's balance sheet. Investors also form their own opinion of Vir Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Vir Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vir Biotechnology's market value can be influenced by many factors that don't directly affect Vir Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vir Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vir Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vir Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vir Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vir Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vir Biotechnology.
02/11/2023 |
| 01/31/2025 |
If you would invest 0.00 in Vir Biotechnology on February 11, 2023 and sell it all today you would earn a total of 0.00 from holding Vir Biotechnology or generate 0.0% return on investment in Vir Biotechnology over 720 days. Vir Biotechnology is related to or competes with CureVac NV, Krystal Biotech, Propanc Biopharma, Blueprint Medicines, Amylyx Pharmaceuticals, Day One, and Viking Therapeutics. Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serio... More
Vir Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vir Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vir Biotechnology upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 5.19 | |||
Information Ratio | 0.0824 | |||
Maximum Drawdown | 71.23 | |||
Value At Risk | (7.29) | |||
Potential Upside | 6.36 |
Vir Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vir Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vir Biotechnology's standard deviation. In reality, there are many statistical measures that can use Vir Biotechnology historical prices to predict the future Vir Biotechnology's volatility.Risk Adjusted Performance | 0.0872 | |||
Jensen Alpha | 0.7344 | |||
Total Risk Alpha | (0.14) | |||
Sortino Ratio | 0.1411 | |||
Treynor Ratio | 0.838 |
Vir Biotechnology Backtested Returns
Vir Biotechnology appears to be unstable, given 3 months investment horizon. Vir Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0531, which indicates the firm had a 0.0531 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Vir Biotechnology, which you can use to evaluate the volatility of the company. Please review Vir Biotechnology's Semi Deviation of 4.57, risk adjusted performance of 0.0872, and Coefficient Of Variation of 1068.43 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Vir Biotechnology holds a performance score of 4. The entity has a beta of 0.98, which indicates possible diversification benefits within a given portfolio. Vir Biotechnology returns are very sensitive to returns on the market. As the market goes up or down, Vir Biotechnology is expected to follow. Please check Vir Biotechnology's sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether Vir Biotechnology's existing price patterns will revert.
Auto-correlation | 0.53 |
Modest predictability
Vir Biotechnology has modest predictability. Overlapping area represents the amount of predictability between Vir Biotechnology time series from 11th of February 2023 to 6th of February 2024 and 6th of February 2024 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vir Biotechnology price movement. The serial correlation of 0.53 indicates that about 53.0% of current Vir Biotechnology price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.53 | |
Spearman Rank Test | 0.41 | |
Residual Average | 0.0 | |
Price Variance | 1.72 |
Vir Biotechnology lagged returns against current returns
Autocorrelation, which is Vir Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vir Biotechnology's stock expected returns. We can calculate the autocorrelation of Vir Biotechnology returns to help us make a trade decision. For example, suppose you find that Vir Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Vir Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vir Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vir Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vir Biotechnology stock over time.
Current vs Lagged Prices |
Timeline |
Vir Biotechnology Lagged Returns
When evaluating Vir Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vir Biotechnology stock have on its future price. Vir Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vir Biotechnology autocorrelation shows the relationship between Vir Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in Vir Biotechnology.
Regressed Prices |
Timeline |
Pair Trading with Vir Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vir Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against Vir Stock
0.49 | NHC | National HealthCare | PairCorr |
0.47 | LFCR | Lifecore Biomedical | PairCorr |
0.44 | DERM | Journey Medical Corp | PairCorr |
The ability to find closely correlated positions to Vir Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vir Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vir Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vir Biotechnology to buy it.
The correlation of Vir Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vir Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vir Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vir Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Vir Stock Analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.